ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
ORIG3N
Industry:
Biotechnology Health Care Medical Personal Health
Founded:
2014-04-10
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.orig3n.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
76.17 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx Amazon IPv6 JsDelivr GoDaddy DNS BootstrapCDN Ubuntu Ruby On Rails Token
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Meryx
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases.
Orchid
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Vascugen
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
ZO Skin Health
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-11-22 | Interleukin Genetics | Interleukin Genetics acquired by ORIG3N | N/A |
Investors List
Haitong International Securities Group
Haitong International Securities Group investment in Series B - ORIG3N
180 Degree Capital
180 Degree Capital investment in Series B - ORIG3N
DEFTA Partners
DEFTA Partners investment in Series B - ORIG3N
KTB Ventures
KTB Ventures investment in Series B - ORIG3N
Spectrum Health Ventures
Spectrum Health Ventures investment in Series B - ORIG3N
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - ORIG3N
Vectr
Vectr investment in Series B - ORIG3N
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - ORIG3N
MMIC Investment Holdings
MMIC Investment Holdings investment in Series B - ORIG3N
Mountain Group Capital
Mountain Group Capital investment in Series B - ORIG3N
Newest Events participated
Participated in SXSW 2017
on 2017-03-10 as exhibitor
Official Site Inspections
http://www.orig3n.com Semrush global rank: 3.72 M Semrush visits lastest month: 3.67 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
